Metformin Efficacy and Safety for Gastric Intestinal Metaplasia

Clinical trial NCT05288153 · COMPLETED

Trial details

NCT number: NCT05288153
Sponsor: Xijing Hospital of Digestive Diseases
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastric Intestinal Metaplasia

Start date: 2022-04-01
Primary completion: 2023-05-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.